Ian Wilding

An internationally-respected key opinion leader in drug development and a serial entrepreneur, his background includes strong scientific, business, managerial and deal-making experience.

Ian has previously founded, managed and developed a number of successful bioscience start-up companies, including Pharmaceutical Profiles Ltd. (recipient of a Frost & Sullivan Excellence in Technology Award) which, as Chief Executive, he grew to over 110 employees and a 10 Million GBP turnover.

He presently sits on the board of Zysis, with previous board positions including Bend Research, Modern Biosciences and R5 Pharmaceuticals.